Group leader
The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.
IBEC and the Blood and Tissue Bank of Catalonia (BST) held a day to explore new collaborations in bioengineering and translational medicine. The meeting, held yesterday at IBEC, highlighted innovative projects, presented a joint PhD programme and strengthened the link between biomedical research and clinical applications.
IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.
The second IBEC-WCH Precision Medicine Conference took place last week in Chengdu, China. This is a partnership between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital (WCH) of Sichuan University, which aims to strengthen scientific collaboration between the two countries.
The demand for engineered skin tissues has surged for both in vitro and in vivo applications, and one of the key points to succeed is to choose an appropriate scaffold … Read more
The innovative device contains a 3D bioprinted channel with structures that mimic intestinal villi and reproduce the compartments of the intestinal mucosa. For the first time, electrodes have been incorporated into the system to monitor the formation of the intestinal barrier in real time. The device is highly versatile and has potential applications in disease modelling and drug screening.
IBEC and Vitala, a spin-off founded by IBEC researchers, are set to participate in three public-private partnership projects, with a combined investment nearing €4 million. These initiatives, backed by the Spanish Ministry of Science and Innovation and the State Research Agency, aim to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge technological approaches, these endeavors aspire to make a positive impact on the fields of medicine and biomedical research.
A recent IBEC study has described how cells contact guidance is not only topography-dependent but also affected by the stiffness of the environment. The work highlights the importance of considering … Read more
Researchers at IBEC have developed a 3D model of the human intestine that simulates the characteristics of the intestinal mucosa and its reliefs. These mini-intestines will make it possible to … Read more
Investigadores del Instituto de Bioingeniería de Cataluña desarrollan un modelo de intestino humano en 3D que simula las características de la mucosa intestinal y su relieve. Este mini-intestino ha permitido recrear … Read more